Alliance revenues — Total Revenues
Bristol-Myers Squibb Alliance revenues — Total Revenues increased by 5.0% to $125.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 19.0%, from $105.00M to $125.00M. Over 3 years (FY 2021 to FY 2024), Alliance revenues — Total Revenues shows a downward trend with a -12.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests successful commercialization of partnered assets or strong performance in co-promoted products, while a decrease may indicate expiring partnerships or underperformance of shared therapeutic portfolios.
Detailed definition
This metric represents the portion of total revenue generated through collaborative arrangements and partnerships with o...
Peer comparison
Most large-cap pharmaceutical firms report similar collaborative income under 'collaboration revenue' or 'alliance revenue' line items, which are standard for companies utilizing R&D partnerships.
bmy_segment_alliance_revenues_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $179.00M | $179.00M | $179.00M | $188.00M | $199.00M | $173.00M | $182.00M | $144.00M | $179.00M | $138.00M | $147.00M | $134.00M | $116.00M | $105.00M | $124.00M | $88.00M | $119.00M | $125.00M |
| QoQ Change | — | +0.0% | +0.0% | +5.0% | +5.9% | -13.1% | +5.2% | -20.9% | +24.3% | -22.9% | +6.5% | -8.8% | -13.4% | -9.5% | +18.1% | -29.0% | +35.2% | +5.0% |
| YoY Change | — | — | — | — | +11.2% | -3.4% | +1.7% | -23.4% | -10.1% | -20.2% | -19.2% | -6.9% | -35.2% | -23.9% | -15.6% | -34.3% | +2.6% | +19.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's alliance revenues — total revenues?
- Bristol-Myers Squibb (BMY) reported alliance revenues — total revenues of $125.00M in Q3 2025.
- How has Bristol-Myers Squibb's alliance revenues — total revenues changed year-over-year?
- Bristol-Myers Squibb's alliance revenues — total revenues increased by 19.0% year-over-year, from $105.00M to $125.00M.
- What is the long-term trend for Bristol-Myers Squibb's alliance revenues — total revenues?
- Over 3 years (2021 to 2024), Bristol-Myers Squibb's alliance revenues — total revenues has grown at a -12.5% compound annual growth rate (CAGR), from $716.00M to $479.00M.
- What does alliance revenues — total revenues mean?
- Revenue earned from collaborative partnerships and profit-sharing agreements with other companies.